Published by Iain Gilbert on 18th September 2018
(Sharecast News) - Viking Therapeutics soared as much as 120% in early trading after the firm revealed a positive set of results from a mid-stage trial of its non-alcoholic fatty liver disease treatment.
URL: http://www.digitallook.com/dl/news/story/28016664/...